Stamford, CT (PressExposure) February 18, 2011 -- Synowledge, LLC, a market leader in pharmacovigilance and IT services for biotechnology, pharmaceutical and manufacturing companies, announced the launch of its new website, http://www.Synowledge.com. With two distinct areas providing comprehensive coverage of the Synowledge drug safety and IT service lines, the refreshed website will serve as an important resource for customers and professionals seeking in-depth and relevant information for their respective industry.
Highlighting Synowledge's rapid global expansion in 2010 (link to expansion press release?); the launch of http://www.Synowledge.com serves as the capstone to a year of record growth in new business wins and corporate development. As it further evolves, the web presence will act as a significant touch-point for key growth areas in the EMEA, APAC and Latin American regions.
"Without a doubt, in today's business landscape, a company is only as credible as its digital presence provides for," said David Ingraham, Director of Sales & Marketing. "Our new online home, http://www.Synowledge.com, aims to provide immediate credibility by making itself an invaluable location and resource for our customers and prospective clients. We think we have achieved this with a clean, intuitive and professional aesthetic, to present an in-depth look at our comprehensive service portfolio."